Biogen Life Sciences products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Rawalpindi · Pakistan
Rawalpindi-based pharmaceutical manufacturer and Biogen Group venture with general, cephalosporin, sterile and topical manufacturing capabilities.
Biogen Life Sciences products in Pakistan
Biogen Life Sciences has 47 medicine presentations registered in Pakistan under 26 brands, covering 22 generic medicines. Most of its products are in Anti-infectives, Dermatology and Fluids & supportive care. Its brands with the most registered strengths and packs are Ceftigen (Ceftriaxone), Cefibio (Cefixime), Genlide (Azithromycin) and Genthate (Colistimethate sodium). 47 products have an official DRAP price on MedInfoBase. See all 26 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Address
- 8-Km, Chakbeli Road, Rawat, Rawalpindi, Pakistan
- Website
- biogenlifesciences.com ↗
- Phone
- +92 51 4418366; +92 51 4418365
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Biogen Life Sciences is priced against the market
41 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aegis 20mg CapsuleRegistry verified | Esomeprazole (as magnesium trihydrate enteric coated pellets) | — | — | — | 108052Official source ↗ | No indexed price | — | — |
| Aegis 40mg CapsuleRegistry verified | Esomeprazole (as magnesium trihydrate enteric coated pellets) | — | — | — | 108053Official source ↗ | No indexed price | — | — |
| Aegis 40mg Injection IVRegistry verified | Esomeprazole as sodium | — | — | — | 111031Official source ↗ | No indexed price | — | — |
| Amikagen | Amikacin | 500 mg/2 mL | Injection | 2mlx5's vial | 124496 | PKR 1,063.25 | — | No comparator |
| Amikagen | Amikacin | 1 g/4 mL | Injection | 4ml vial | 124497 | PKR 429.61 | PKR 107.40/mL | No comparator |
| Aqgen | Sodium chloride | 2.6 g | Sachet | 20's | 111765 | PKR 325.66 | PKR 16.28/sachet | 🔒 Pharma Pro |
| Betnogen | Betamethasone | 0.1 % | Cream | 15gm | 111971 | PKR 44.14 | PKR 2.94/g | 🔒 Pharma Pro |
| Betnogen | Betamethasone | 0.1 % | Cream | 5gm | 111971 | PKR 16.18 | PKR 3.24/g | 🔒 Pharma Pro |
| Betnogen Ointment | Betamethasone | 0.1 % | Ointment | 15gm | 111973 | PKR 44.14 | PKR 2.94/g | 🔒 Pharma Pro |
| Betnogen Ointment | Betamethasone | 0.1 % | Ointment | 5gm | 111973 | PKR 16.18 | PKR 3.24/g | 🔒 Pharma Pro |
| Bi-Dex 30mg CapsuleRegistry verified | Dexlansoprazole dual delayed released pellets 22.5% eq. to Dexlansoprazole | — | — | — | 124507Official source ↗ | No indexed price | — | — |
| Bi-Dex 6Omg CapsuleRegistry verified | Dexlansoprazole (as dual delayed release pellets) | — | — | — | 123586Official source ↗ | No indexed price | — | — |
| Bio-Om | Omeprazole | 20 mg | Capsule | 14's | 109355 | PKR 233.94 | PKR 16.71/capsule | 🔒 Pharma Pro |
| Bio-Om | Omeprazole | 40 mg | Injection | 1's | 111032 | PKR 487.39 | PKR 487.39/vial/unit | 🔒 Pharma Pro |
| Biobactum 1g InjectionRegistry verified | Cefoperazone (as sodium), Sulbactam as Sodium | — | — | — | 113078Official source ↗ | No indexed price | — | — |
| Biobactum 2g InjectionRegistry verified | Cefoperazone (as sodium), Sulbactam as Sodium | — | — | — | 113079Official source ↗ | No indexed price | — | — |
| Biocurium | Atracurium besylate | 50 mg/mL | Solution for infusion | 5's x5ml Ampoules) | 119476 | PKR 1,394.18 | — | No comparator |
| Biocurium | Atracurium besylate | 50 mg/mL | Solution for infusion | 1's x5ml Ampoule | 119476 | PKR 278.84 | — | No comparator |
| Biodronic | Zoledronic acid | 5 mg/100 mL | IV infusion | 100ml | 123791 | PKR 30,877.63 | PKR 308.78/mL | 🔒 Pharma Pro |
| Biopene | Meropenem | 500 mg | Injection | 1's | 111766 | PKR 2,209.94 | PKR 2,209.94/vial/unit | 🔒 Pharma Pro |
| Biopene | Meropenem | 1 g | Injection | 1's | 111767 | PKR 4,130.73 | PKR 4,130.73/vial/unit | 🔒 Pharma Pro |
| Cainli 2ml | Lidocaine | 1 % | Injection | 2ml | 108058 | PKR 8.46 | PKR 4.23/mL | 🔒 Pharma Pro |
| Cefibio | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 108049 | PKR 487.39 | PKR 16.25/mL | 🔒 Pharma Pro |
| Cefibio | Cefixime | 400 mg | Capsule | 5's | 108050 | PKR 495.41 | PKR 99.08/capsule | 🔒 Pharma Pro |
| Cefibio | Cefixime | 200 mg | Capsule | 5's | 117408 | PKR 378.60 | PKR 75.72/capsule | 🔒 Pharma Pro |
| Cefibio Eavh 5ml of reconstituted | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 108048 | PKR 292.43 | PKR 9.75/mL | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 250 mg | Injection | Vial | 108041 | PKR 164.09 | PKR 164.09/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 500 mg | Injection | 1's | 108042 | PKR 276.19 | PKR 276.19/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 1 g | IM injection | 1's | 108043 | PKR 521.50 | PKR 521.50/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 250 mg | Injection | 1's | 108044 | PKR 164.09 | PKR 164.09/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 500 mg | Injection | 1's | 108045 | PKR 276.19 | PKR 276.19/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 1 g | IV injection | 1's | 108046 | PKR 521.50 | PKR 521.50/vial/unit | 🔒 Pharma Pro |
| Ceftigen | Ceftriaxone | 2 g | IV injection | 1's | 108047 | PKR 731.08 | PKR 731.08/vial/unit | 🔒 Pharma Pro |
| Cobiso-Nrk 100mg TabletRegistry verified | SILDENAFIL CITRATE equivalent to SILDENAFIL | — | — | — | 136697Official source ↗ | No indexed price | — | — |
| Cobiso-Nrk 50mg TabletRegistry verified | Sildenafil Citrate | — | — | — | 136702Official source ↗ | No indexed price | — | — |
| Comydil | Vancomycin | 1 g | Injection | 1's | 124498 | PKR 2,333.95 | PKR 2,333.95/vial/unit | 🔒 Pharma Pro |
| DW-10 | Water for Injection | 10 mL | Injection | 10ml | 108057 | PKR 19.25 | PKR 1.93/mL | 🔒 Pharma Pro |
| DW-5 | Water for Injection | 5 mL | Injection | 5mlx100's | 108056 | PKR 896.79 | PKR 1.79/mL | 🔒 Pharma Pro |
| Floxagen | Moxifloxacin | 400 mg | Tablet | 5's | 117407 | PKR 981.09 | PKR 196.22/tablet | 🔒 Pharma Pro |
| Gen-D-3-Soft | Cholecalciferol | 50,000 IU | Softgel capsule | 100's | 111768 | PKR 340.80 | PKR 3.41/capsule | No comparator |
| Genlide | Azithromycin | 500 mg | Tablet | 6's | 108199 | PKR 446.77 | PKR 74.46/tablet | 🔒 Pharma Pro |
| Genlide | Azithromycin | 250 mg | Tablet | 6's | 108200 | PKR 243.69 | PKR 40.62/tablet | 🔒 Pharma Pro |
| Genlide | Azithromycin | 250 mg | Capsule | 6's | 109585 | PKR 248.57 | PKR 41.43/capsule | 🔒 Pharma Pro |
| Genthate | Colistimethate sodium | 1 MIU | Injection | 1's | 108054 | PKR 1,199.84 | PKR 1,199.84/vial/unit | 🔒 Pharma Pro |
| Genthate | Colistimethate sodium | 2 MIU | Injection | 1's | 108055 | PKR 2,000.12 | PKR 2,000.12/vial/unit | 🔒 Pharma Pro |
| Genthate | Colistimethate sodium | 4.5 MIU | Injection | 1's | 121550 | PKR 4,009.17 | PKR 4,009.17/vial/unit | 🔒 Pharma Pro |
| Linzogen | Linezolid | 600 mg/300 mL | Solution for infusion | 1's vial | 115676 | PKR 1,239.27 | PKR 1,239.27/vial/unit | No comparator |
| Linzogen | Linezolid | 600 mg | Tablet | 12's | 117406 | PKR 5,279.28 | PKR 439.94/tablet | 🔒 Pharma Pro |
| Omjent | Omeprazole | 40 mg | Capsule | 14's | 108051 | PKR 406.15 | PKR 29.01/capsule | 🔒 Pharma Pro |
| Oseltagen | Oseltamivir | 75 mg | Capsule | 10's | 106098 | PKR 1,218.46 | PKR 121.85/capsule | 🔒 Pharma Pro |
All 26 Biogen Life Sciences brands in Pakistan
- Amikagen Amikacin · 1 g/4 mL injection, 500 mg/2 mL injection
- Aqgen Sodium chloride · 2.6 g sachet
- Betnogen Betamethasone · 0.1 % cream
- Betnogen Ointment Betamethasone · 0.1 % ointment
- Bio-Om Omeprazole · 20 mg capsule, 40 mg injection
- Biocurium Atracurium besylate · 50 mg/mL infusion
- Biodronic Zoledronic acid · 5 mg/100 mL infusion
- Biopene Meropenem · 1 g injection, 500 mg injection
- Cainli 2ml Lidocaine · 1 % injection
- Cefibio Cefixime · 200 mg capsule, 200 mg/5 mL suspension, 400 mg capsule
- Cefibio Eavh 5ml of reconstituted Cefixime · 100 mg/5 mL suspension
- Ceftigen Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Comydil Vancomycin · 1 g injection
- DW-10 Water for Injection · 10 mL injection
- DW-5 Water for Injection · 5 mL injection
- Floxagen Moxifloxacin · 400 mg tablet
- Gen-D-3-Soft Cholecalciferol · 50,000 IU capsule
- Genlide Azithromycin · 250 mg tablet, 250 mg capsule, 500 mg tablet
- Genthate Colistimethate sodium · 1 MIU injection, 2 MIU injection, 4.5 MIU injection
- Linzogen Linezolid · 600 mg tablet, 600 mg/300 mL infusion
- Omjent Omeprazole · 40 mg capsule
- Oseltagen Oseltamivir · 75 mg capsule
- Permgen Permethrin · 5 % lotion
- Predgen Methylprednisolone · 125 mg injection
- Succigen Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Terbigen Terbinafine · 1 % cream
Biogen Life Sciences: common questions
How many products does Biogen Life Sciences have in Pakistan?
Biogen Life Sciences has 47 registered medicine presentations in Pakistan, sold under 26 brands and covering 22 generic medicines.
What are the main brands of Biogen Life Sciences?
By number of registered strengths and packs, its largest brands are Ceftigen (Ceftriaxone), Cefibio (Cefixime), Genlide (Azithromycin), Genthate (Colistimethate sodium) and Succigen (Hydrocortisone). This is not a sales ranking.
Which therapy areas does Biogen Life Sciences cover?
The most products are in Anti-infectives (28), Dermatology (7), Fluids & supportive care (3), Gastrointestinal & hepatology (3) and Anesthesia & critical care (3).
Where can I see Biogen Life Sciences medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.